Cargando…
Ganglioside-monosialic acid (GM1) for prevention of chemotherapy-induced peripheral neuropathy: a meta-analysis with trial sequential analysis
BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting side effect that largely remains an unresolved clinical issue, leading to long-term morbidity. This meta-analysis aimed to evaluate the efficacy and safety of Ganglioside-monosialic acid (GM1) in preventing CIPN. METHOD...
Autores principales: | Wu, Shaoyong, Bai, Xiaohui, Guo, Caixia, Huang, Zhimei, Ouyang, Handong, Huang, Jingxiu, Zeng, Weian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564974/ https://www.ncbi.nlm.nih.gov/pubmed/34727879 http://dx.doi.org/10.1186/s12885-021-08884-4 |
Ejemplares similares
-
Ganglioside-monosialic acid (GM1) prevents oxaliplatin-induced peripheral neurotoxicity in patients with gastrointestinal tumors
por: Zhu, Yanyun, et al.
Publicado: (2013) -
Ganglioside Monosialic Acid Alleviates Peripheral Neuropathy Induced by Utidelone Plus Capecitabine in Metastatic Breast Cancer From a Phase III Clinical Trial
por: Xu, Junnan, et al.
Publicado: (2020) -
Internal jugular vein versus subclavian vein as the percutaneous insertion site for totally implantable venous access devices: a meta-analysis of comparative studies
por: Wu, Shaoyong, et al.
Publicado: (2016) -
Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review
por: Zhang, Wenchao, et al.
Publicado: (2019) -
Subacute Sensorimotor Neuropathy Accompanied by Anti-ganglioside GM1 Antibody in a Patient with Lung Cancer
por: Kanaji, Nobuhiro, et al.
Publicado: (2018)